Crescent Biopharma, Inc. · Brief

Next report

3 days

Nov 5 · before openest.Q3 FY26

Expected move

No implied move.

—≥ implied

Q2 FY26—▲+1.69%—

quarterimplied−5%0+5%realized×

Q2 FY26—▲+1.69%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2 of 4

80managers reporting a position in the latest quarterly filings13F · Jun 30 '26

13managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

Bear1

2 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

CBIO report session

No linked exposure.

Oct 22impliedImplied move: ±34.1% into Nov 5 earnings (Oct 22 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.